Sponsors Seeing Subtle Differences With US FDA Meetings In Coronavirus Era
Mass-telework is changing some meeting dynamics, like reducing the number of questions asked by agency staff.
You may also be interested in...
In less than three weeks, the number of clinical trials for potential treatments has jumped to 72, according to the FDA’s Coronavirus Treatment Acceleration Program.
Productivity may suffer under coronavirus-mandated telework despite workforce diligence, experts say.
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.